Julien Ablain Selected Research

Julien Ablain Research Topics

12	Neoplasms (Cancer) 01/2022 - 12/2010
8	Acute Promyelocytic Leukemia 12/2014 - 12/2009
6	Leukemia 12/2015 - 12/2009
4	Melanoma (Melanoma, Malignant) 01/2022 - 04/2016
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Genetic Translocation (Chromosomal Translocation) 11/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2014
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2010
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2009

7	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2014 - 12/2009
4	Proteins (Proteins, Gene)FDA Link 04/2014 - 12/2009
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2014 - 07/2011
2	Biological ProductsIBA 01/2022 - 11/2014
2	Pharmaceutical PreparationsIBA 01/2021 - 07/2011
2	Retinoic Acid Receptor alphaIBA 11/2014 - 12/2009
2	RetinoidsIBA 04/2014 - 04/2013
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2014 - 02/2013
1	Small Cytoplasmic RNAIBA 01/2021
1	VemurafenibIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 11/2018
1	NucleotidesIBA 04/2016
1	Histone Deacetylase InhibitorsIBA 04/2014
1	Arsenic Trioxide (Trisenox)FDA Link 02/2014
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2013
1	8-((4-chlorophenyl)thio)cyclic-3',5'-AMPIBA 02/2013
1	Therapeutic UsesIBA 02/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2011
1	ArsenicIBA 07/2011
1	Phosphotransferases (Kinase)IBA 07/2011
1	Transcription Factors (Transcription Factor)IBA 07/2011
1	Oncogene Proteins (Oncogene Protein)IBA 07/2011
1	Drug CombinationsIBA 12/2010
1	ChromatinIBA 12/2009